Addressing disparities in biologic drug development in the United States
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:148 |
|---|---|
| Enthalten in: |
The Journal of allergy and clinical immunology - 148(2021), 5 vom: 15. Nov., Seite 1154-1156 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hvisdas, Christopher [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Allergy |
|---|
| Anmerkungen: |
Date Completed 06.12.2021 Date Revised 14.12.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jaci.2021.09.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330719955 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330719955 | ||
| 003 | DE-627 | ||
| 005 | 20231225211905.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaci.2021.09.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1102.xml |
| 035 | |a (DE-627)NLM330719955 | ||
| 035 | |a (NLM)34530019 | ||
| 035 | |a (PII)S0091-6749(21)01389-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hvisdas, Christopher |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Addressing disparities in biologic drug development in the United States |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.12.2021 | ||
| 500 | |a Date Revised 14.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Allergy | |
| 650 | 4 | |a clinical trials | |
| 650 | 4 | |a disparities | |
| 650 | 7 | |a Biological Products |2 NLM | |
| 700 | 1 | |a Louisias, Margee |e verfasserin |4 aut | |
| 700 | 1 | |a Laidlaw, Tanya M |e verfasserin |4 aut | |
| 700 | 1 | |a Akenroye, Ayobami |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of allergy and clinical immunology |d 1971 |g 148(2021), 5 vom: 15. Nov., Seite 1154-1156 |w (DE-627)NLM000018449 |x 1097-6825 |7 nnns |
| 773 | 1 | 8 | |g volume:148 |g year:2021 |g number:5 |g day:15 |g month:11 |g pages:1154-1156 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaci.2021.09.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 148 |j 2021 |e 5 |b 15 |c 11 |h 1154-1156 | ||